June 22
11:00 am - 12:00 pm EDT


Innovation in drug product manufacturing: how do we bring new therapies to patients faster?

The past year has proven that innovations in drug product technology can be implemented faster, to the benefit of patients. The focus of this webinar is manufacturing speed and agility, standardization and the rewards and risks of technology adoption. Our panel of experts will share their experiences and key considerations for the future of drug product operations.

Watch this webinar to:
  • Understand the contribution of new technologies in reducing risk and increasing speed to patients in drug product.
  • Learn about manufacturing strategies for advanced modalities—how do you overcome obstacles when there is no established process?
  • Hear the opinion of experts on how COVID has changed manufacturing approaches and willingness to innovate.

register now
register for the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.

Matthew Snyder

Matthew Snyder

Associate Director, Engineering & Facilities, Center for Breakthrough Medicines at the Discovery Labs

Matthew has 25 years of biopharmaceutical industry experience with multiple operating companies. At the Center for Breakthrough Medicines at the Discovery Labs, he is responsible for establishing the critical support services necessary for laboratory and manufacturing operations, including technical engineering support for process operations and facility design. Previously, Matthew was Senior Project Manager with CRB Consulting Engineers, where he led engineering design projects with specific focus on biopharmaceutical and advanced technology facilities and operations. Matthew is the Past President of Delaware Valley Chapter of ISPE, and remains an engaged member of the industry professional society. He holds a Bachelor of Science in chemical engineering from Drexel University.

Gary J. Mills

Gary J. Mills

Director, Sterile Drug Product Development, GSK

Gary has over 32 years of experience in the design, development, technical transfer and commercialization of aseptic and purification processes associated with the production of biopharmaceuticals. To date, he has contributed to the successful commercialization of four biologics, two complex generics, one imaging contrast agent and one reusable auto-injector device for prefilled syringes. Gary is currently responsible for the oversight of parenteral drug product manufacturing at GSK’s contract manufacturing organizations, including management of technology transfer, scale-up, process optimization and trouble-shooting, and validation activities.

Brent Lieffers

Brent Lieffers

Senior Director of Operations, Singota Solutions

Brent is the Senior Director of Operations at Singota Solutions. He has nearly 30 years in the pharmaceutical industry, from API manufacture through aseptic filling to final drug product packaging, in operations ranging from small clinical to large commercial scale production. His contributions in multiple start-ups have included technology transfer, equipment selection and validation, regulatory submission preparation, and managing both regulatory and client inspections. Brent has strengths in continuous improvement, process optimization, and cross-function/facility harmonization. He received his Bachelor of Science from Pepperdine University.­­­­

Arsalan Arif

arsalan arif

Founder & CEO, Endpoints News

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.